Drawing for AMERICAN PHARMACEUTICAL DISTRIBUTORS

USPTO serial 87883775

AMERICAN PHARMACEUTICAL DISTRIBUTORS

Reviewed by CopyMark Law Group

Reg. 5718251Status 701Registered
Filing date
Status date
Registration date
Apr 2, 2019
Examiner
BROOKSHIRE, DAVID AARON
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with AMERICAN PHARMACEUTICAL DISTRIBUTORS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Wholesale distributorship services in the field of pharmaceutical preparations and drugsACTIVEMar 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jul 14, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jul 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 2, 2025ES8RTEAS SECTION 8 RECEIVED—
Apr 2, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 2, 2019R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Feb 28, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 22, 2019ALIEASSIGNED TO LIE—
Feb 7, 2019CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Feb 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 6, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2018DOCKASSIGNED TO EXAMINER—
Apr 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance